A brief history of urine examination - From ancient uroscopy to 21st century urinomics

by Tatjana Crnogorac-Jurcevic
Published 2024-01-01

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review

by Iveta Mikolaskova, Tatjana Crnogorac-Jurcevic, Bozena Smolkova, Luba Hunakova
Published 2023-01-01

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review

by Greta Brezgyte, Vinay Shah, Daria Jach, Tatjana Crnogorac-Jurcevic
Published 2021-05-01

Demographic, clinical, and pathological features of early onset pancreatic cancer patients

by Chara Ntala, Silvana Debernardi, Roger M. Feakins, Tatjana Crnogorac-Jurcevic
Published 2018-09-01

Non-Invasive Biomarkers for Early Lung Cancer Detection

by Harman Saman, Afsheen Raza, Kalyani Patil, Shahab Uddin, Tatjana Crnogorac-Jurcevic
Published 2022-11-01

Analysis of urinary potassium isotopes and association with pancreatic health: healthy, diabetic and cancerous states

by Kathrin Schilling, Kathrin Schilling, Heng Chen, Ronald A. Glabonjat, Silvana Debernardi, Oleg Blyuss, Ana Navas-Acien, Alex N. Halliday, Tatjana Crnogorac-Jurcevic
Published 2024-04-01

Molecular analysis of precursor lesions in familial pancreatic cancer.

by Tatjana Crnogorac-Jurcevic, Claude Chelala, Sayka Barry, Tomohiko Harada, Vipul Bhakta, Sam Lattimore, Stipo Jurcevic, Mary Bronner, Nicholas R Lemoine, Teresa A Brentnall
Published 2013-01-01

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling

by Wasfi Alrawashdeh, Richard Jones, Laurent Dumartin, Tomasz P. Radon, Pedro R. Cutillas, Roger M. Feakins, Branko Dmitrovic, Ihsan Ekin Demir, Guralp O. Ceyhan, Tatjana Crnogorac‐Jurcevic
Published 2019-05-01

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma

by Silvana Debernardi, Lukasz Liszka, Chara Ntala, Katja Steiger, Irene Esposito, Emanuela Carlotti, Ann‐Marie Baker, Stuart McDonald, Trevor Graham, Branko Dmitrovic, Roger M. Feakins, Tatjana Crnogorac‐Jurcevic
Published 2024-03-01

Splice variants as novel targets in pancreatic ductal adenocarcinoma

by Jun Wang, Laurent Dumartin, Andrea Mafficini, Pinar Ulug, Ajanthah Sangaralingam, Namaa Audi Alamiry, Tomasz P. Radon, Roberto Salvia, Rita T. Lawlor, Nicholas R. Lemoine, Aldo Scarpa, Claude Chelala, Tatjana Crnogorac-Jurcevic
Published 2017-06-01

Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.

by Kay L Pogue-Geile, Ru Chen, Mary P Bronner, Tatjana Crnogorac-Jurcevic, Kara White Moyes, Sally Dowen, Carol A Otey, David A Crispin, Ryan D George, David C Whitcomb, Teresa A Brentnall
Published 2006-12-01

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

by Michelle R. Goulart, Jennifer Watt, Imran Siddiqui, Rita T. Lawlor, Ahmet Imrali, Christine Hughes, Amina Saad, Joanne ChinAleong, Chris Hurt, Catrin Cox, Roberto Salvia, Alberto Mantovani, Tatjana Crnogorac-Jurcevic, Somnath Mukherjee, Aldo Scarpa, Paola Allavena, Hemant M. Kocher
Published 2021-06-01

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

by Silvana Debernardi, Harrison O'Brien, Asma S Algahmdi, Nuria Malats, Grant D Stewart, Marija Plješa-Ercegovac, Eithne Costello, William Greenhalf, Amina Saad, Rhiannon Roberts, Alexander Ney, Stephen P Pereira, Hemant M Kocher, Stephen Duffy, Oleg Blyuss, Tatjana Crnogorac-Jurcevic
Published 2020-12-01